Metabolism of a lipid nanoemulsion resembling low-density lipoprotein in patients with grade III obesity

Clinics

Volumn 65, Issue 1, 2010, Pages 23-27

  Dantas, Simone Alves ^a   Ficker, Elisabeth Salvatori ^a   Vinagre, Carmen G C ^a   Ianni, Barbara Maria ^a   Maranhão, Raul Cavalcante ^a   Mady, Charles ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Artificial emulsions with lipidic structure; Grade III obesity; LDL metabolism; Radioisotopes; Triglyceride

Indexed keywords

LIPID EMULSION; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NANOPARTICLE;

ADULT; BLOOD; CASE CONTROL STUDY; CHEMISTRY; FEMALE; HUMAN; MALE; MIDDLE AGED; OBESITY;

ADULT; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; FAT EMULSIONS, INTRAVENOUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NANOPARTICLES; OBESITY;

EID: 77649154329     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322010000100005     Document Type: Article

References (24)

1. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest. 1983;72:1150-62.
2. Lamon-Fava S, Wilson PW, Schaefer EJ. Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 1996;16:509-15.
3. Denke MA, Sempos CT, Grundy SM. Excess body weight. An under-recognized contributor to dyslipidemia in White American women. Arch Intern Med. 1994;154:401-10.
4. Seidell JC, Cigolini M, Charzewska J, Ellsinger BM, Di Biase G. Fat distribution in European women: a comparison of anthropometric measurements in relation to cardiovascular risk factors. Int J Epidemiol. 1990;19:303-8.
5. Vinagre CG, Ficker ES, Finazzo C, Alves MJ, de Angelis K, Irigoyen MC, et al. Enhanced removal from the plasma of LDL-like nanoemulsion cholesteryl ester in trained men compared with sedentary healthy men. J Appl Physiol. 2007;103:1166-71.
6. Friedewald WT, Levy RI, Fredrickson DD. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
7. Ginsburg GS, Small DM, Atkinson D. Microemulsion of phospholipids and cholesterol esters Protein-free models of low density lipoprotein. J Biol Chem.1982;257:8216-27.
8. Maranhão RC, César TB, Pedroso-Mariani SR, Hirata MH, Mesquita CH. Metabolic behavior in rats of a nonprotein microemulsion resembling low density lipoprotein. Lipids. 1993;28:691-6.
9. Sowby FS. Radiation protection. ICRP publication 30. part I. Limits for intakes of radionuclides by workers. In: Sowby FS. Oxford: Pergamon; 1984.
10. Maranhao RC, Graziani SR, Yamaguchi N, Melo RF, Latrilha MC, Rodrigues DG, et al. Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients. Cancer Chemother Pharmacol. 2002;49:487-98.
11. Mesquita CH. Cinética do quilomícron marcado com 3H-TG e 14C-CE. Análise compartimental auxiliar. São Paulo: Instituto de Pesquisas Energéticas e Nucleares (IPEN), 1994.
12. Swarnakar S, Reyland ME, Deng J, Azhar S, Williams DL. Selective uptake of low density lipoprotein-cholesterol ester is enhanced by inducible apolipoprotein E expression in cultured mouse adrenocortical cells. J Biol Chem. 1998;273:12140-7.
13. Maranhão RC, Feres MC, Martins MT, Mesquita CH, Toffoletto O, Vinagre CGC, et al. Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease. Atherosclerosis. 1996;126:15-25.
14. Borba EF, Bonfa E, Vinagre CG, Ramires JA, Maranhao RC. Chylomicron metabolism is markedly altered in systemic lupus erythematosus. Arthritis Rheum. 2000;43:1033-40.
15. Vinagre CGC, Stolf NA, Bocchi E, Maranhao RC. Chylomicron metabolism in patients submitted to cardiac transplantation. Transplantation. 2000;69:532-7.
16. Santos RD, Sposito AC, Ventura LI, César LA, Ramires JA, Maranhao RC. Effect of pravastatin on plasma removal of a chylomicron-like emulsion in men with coronary artery disease. Am J Cardiol. 2000;85:1163-6.
17. Santos RD, Ventura LI, Sposito AC, Schreiber R, Ramires JA, Maranhao RC. The effects of gemfibrozilupon the metabolism of chylomicron-like emulsions in patientswith endogenous hypertriglyceridemia. Cardiovasc Res. 2001;49:456-65.
18. César TB, Oliveira MR, Mesquita CH, Maranhão RC. High cholesterol intake modifies chylomicron metabolism in normolipidemic young men. J Nutr. 2006;136:971-6.
19. Hosni JJ, Vinagre CG, Mady C, Maranhão RC. Lipolysis of emulsion models of triglyceride-rich lipoproteins is altered in male patients with abdominal aorta aneurysm. Braz J Med Biol Res. 2007;40:305-7.
20. Oliveira MR, Maranhão RC. Plasma kinetics of a chylomicron-like emulsion in normolipidemic obese women after a short-period weight loss by energy-restricted diet. Metabolism. 2002;51:1097-103.
21. Oliveira MR, Maranhão RC. Relationships in women between body mass index and the intravascular metabolism of chylomicron-like emulsions. Int J Obes Relat Metab Disord. 2004;28:1471-8.
22. Meier JJ, Gethmann A, Götze O, Gallwitz B, Holst JJ, Schmidt WE, et al. Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans. Diabetologia 2006;49:452-8.
23. Adeli K, Lewis GF. Intestinal lipoprotein overproduction in insulin-resistant states. Curr Opin Lipidol. 2008;19:221-8.
24. de Lemos HP Jr, Atallah AN, de Lemos AL. Can sibutramine alter systemic blood pressure in obese patients? Systematic review and meta-analysis. Sao Paulo Med J. 2008;126:342-6.